Hannah Kristin Cain, MS | |
175 Medpark Dr, Somerset, KY 42503-2734 | |
(606) 679-1761 | |
Not Available |
Full Name | Hannah Kristin Cain |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 175 Medpark Dr, Somerset, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235626607 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 241152 (Kentucky) | Primary |
Provider Name | To Go Therapy |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1750007035 PECOS PAC ID: 2961873013 Enrollment ID: O20230127000811 |
News Archive
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil beam scanning treatments at its Proton Beam Cancer Center. On 15 May, the center carried out the world's first patient treatment using RayStation together with Mitsubishi Electric's proton therapy system, with a plan created in RayStation 6.
Researchers at UCSD and UC Irvine have captured on video for the first time chemical signals that traverse human cells in response to tiny mechanical jabs, like waves spreading from pebbles tossed into a pond. The scientists released the videos and technical details that explain how the visualization effect was created as part of a paper published in the April 21 issue of Nature.
Portico Systems, the leader in Integrated Provider Management (IPM) solutions, announced today that it has been named Emerging Technology Company of the Year by The Eastern Technology Council at last night's 17th Annual Enterprise Awards. The Emerging Technology Company award acknowledges product or service innovation and the ability of the management team to fuel growth.
Researchers at Indiana University School of Medicine have successfully reprogrammed a glial cell type in the central nervous system into new neurons to promote recovery after spinal cord injury-revealing an untapped potential to leverage the cell for regenerative medicine.
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Hannah Kristin Cain, MS 175 Medpark Dr, Somerset, KY 42503-2734 Ph: (606) 679-1761 | Hannah Kristin Cain, MS 175 Medpark Dr, Somerset, KY 42503-2734 Ph: (606) 679-1761 |
News Archive
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil beam scanning treatments at its Proton Beam Cancer Center. On 15 May, the center carried out the world's first patient treatment using RayStation together with Mitsubishi Electric's proton therapy system, with a plan created in RayStation 6.
Researchers at UCSD and UC Irvine have captured on video for the first time chemical signals that traverse human cells in response to tiny mechanical jabs, like waves spreading from pebbles tossed into a pond. The scientists released the videos and technical details that explain how the visualization effect was created as part of a paper published in the April 21 issue of Nature.
Portico Systems, the leader in Integrated Provider Management (IPM) solutions, announced today that it has been named Emerging Technology Company of the Year by The Eastern Technology Council at last night's 17th Annual Enterprise Awards. The Emerging Technology Company award acknowledges product or service innovation and the ability of the management team to fuel growth.
Researchers at Indiana University School of Medicine have successfully reprogrammed a glial cell type in the central nervous system into new neurons to promote recovery after spinal cord injury-revealing an untapped potential to leverage the cell for regenerative medicine.
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.
› Verified 9 days ago
Mrs. Tamara B Cranfill, CCC/SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 353 Bogle St, Suite 203, Somerset, KY 42503 Phone: 606-679-1761 Fax: 606-678-0971 | |
Allison Kathryn Parrott, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tower Cir, Somerset, KY 42503 Phone: 606-416-5139 | |
Dr. Sue Ann Losey, ED. D, CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 Allen Dr, Somerset, KY 42503 Phone: 606-679-2250 | |
Mackenzie Flynn Epperson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tower Cir, Somerset, KY 42503 Phone: 606-416-5139 Fax: 606-416-5239 | |
Alisha Spinks, M.S., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 303 Second St, Somerset, KY 42501 Phone: 606-677-1166 | |
Brittany Gaines, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 303 Second St, Somerset, KY 42501 Phone: 606-677-1166 | |
Ginger Lee Davis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Norfleet Dr, Somerset, KY 42501 Phone: 606-678-5104 |